glutathione peroxidase 4 gpx4 Directly targeting may be more effective than disrupting glutathione on ferroptosis-based cancer therapy Glutathione Peroxidase 4/GPX4 Antibody, Novus
Description
Study done by van Eenige R, et al

Glassman, C

Abcam, Cambridge, United Kingdom), polyclonal anti-rabbit GCLM (1:1000, 14241-1-AP

Endothelium-targeted deletion of microRNA-15a/16-1 promotes poststroke angiogenesis and improves long-term neurological recovery

Because therapy is fully customized, pricing is discussed during your consultation after your treatment plan is established

10.1186/1475-2867-12-11 Cancer Cell Int
